ADVANCED ENZYME TECHNOLOGIES
Back to Cashflow Statement
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹157 Cr | ₹142 Cr | ₹141 Cr | ₹140 Cr | ₹122 Cr |
What is the latest Cash Flow from Operating Activities ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹157 Cr |
| Mar2025 | ₹142 Cr |
| Mar2024 | ₹141 Cr |
| Mar2023 | ₹140 Cr |
| Mar2022 | ₹122 Cr |
How is Cash Flow from Operating Activities of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹157 Cr | 10.02 | |
| Mar2025 | ₹142 Cr | 0.80 | |
| Mar2024 | ₹141 Cr | 0.72 | |
| Mar2023 | ₹140 Cr | 14.78 | |
| Mar2022 | ₹122 Cr | - | |
Compare Cash Flow from Operating Activities of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,101.7 Cr | -0.2% | 6.3% | -14.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,688.0 Cr | -1.4% | 6.3% | 7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹295,080.0 Cr | -1.8% | 20.6% | 70.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,677.0 Cr | -1.9% | 2.4% | 22.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,852.0 Cr | 0.8% | 12.6% | 12.3% | Stock Analytics | |
| CIPLA | ₹111,731.0 Cr | -2.4% | 4.4% | -8.3% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -0.2% |
6.3% |
-14.8% |
| SENSEX | 1.8% |
11.1% |
-1.6% |
You may also like the below Video Courses